1. Home
  2. NEO vs SCSC Comparison

NEO vs SCSC Comparison

Compare NEO & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • SCSC
  • Stock Information
  • Founded
  • NEO 2001
  • SCSC 1992
  • Country
  • NEO United States
  • SCSC United States
  • Employees
  • NEO N/A
  • SCSC N/A
  • Industry
  • NEO Precision Instruments
  • SCSC Retail: Computer Software & Peripheral Equipment
  • Sector
  • NEO Health Care
  • SCSC Technology
  • Exchange
  • NEO Nasdaq
  • SCSC Nasdaq
  • Market Cap
  • NEO 1.0B
  • SCSC 892.3M
  • IPO Year
  • NEO 1999
  • SCSC 1994
  • Fundamental
  • Price
  • NEO $8.34
  • SCSC $45.40
  • Analyst Decision
  • NEO Buy
  • SCSC
  • Analyst Count
  • NEO 9
  • SCSC 0
  • Target Price
  • NEO $12.63
  • SCSC N/A
  • AVG Volume (30 Days)
  • NEO 2.7M
  • SCSC 314.8K
  • Earning Date
  • NEO 11-04-2025
  • SCSC 11-06-2025
  • Dividend Yield
  • NEO N/A
  • SCSC N/A
  • EPS Growth
  • NEO N/A
  • SCSC N/A
  • EPS
  • NEO N/A
  • SCSC 3.00
  • Revenue
  • NEO $689,189,000.00
  • SCSC $3,040,810,000.00
  • Revenue This Year
  • NEO $10.40
  • SCSC $5.79
  • Revenue Next Year
  • NEO $10.11
  • SCSC $4.60
  • P/E Ratio
  • NEO N/A
  • SCSC $15.15
  • Revenue Growth
  • NEO 9.70
  • SCSC N/A
  • 52 Week Low
  • NEO $4.72
  • SCSC $28.75
  • 52 Week High
  • NEO $19.12
  • SCSC $53.90
  • Technical
  • Relative Strength Index (RSI)
  • NEO 64.46
  • SCSC 59.50
  • Support Level
  • NEO $7.36
  • SCSC $42.57
  • Resistance Level
  • NEO $8.29
  • SCSC $46.25
  • Average True Range (ATR)
  • NEO 0.45
  • SCSC 1.59
  • MACD
  • NEO 0.06
  • SCSC -0.02
  • Stochastic Oscillator
  • NEO 74.47
  • SCSC 86.53

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About SCSC ScanSource Inc.

ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: